Safety study of eltrekibart in healthy adults
This is an early-stage safety trial testing a new drug called eltrekibart in people without serious health conditions. Researchers want to understand how safe the drug is and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in generally good health with no serious ongoing medical conditions
- You weigh at least 45 kilograms (about 99 pounds)
- Your body mass index (BMI, a measure of height-to-weight ratio) is between 18.5 and 28.5
- You have not had a serious infection requiring hospitalization or IV antibiotics in the past 3 months
- You do not have a weak immune system or take medications that suppress your immunity
- If you are able to become pregnant, you cannot be pregnant, planning to become pregnant, or breastfeeding during the study or for 16 weeks after receiving the study drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new experimental medicine called LY4302814 in healthy volunteers to see if it is safe and how the body processes it. By enrolling healthy people first, researchers can understand the drug's basic safety profile before testing it in patients with medical conditions.
This study tests a new medicine, called BLKR201, for the first time in people. It is given to healthy volunteers to see how safe it is and how the body handles it.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.